|
Volumn 89, Issue 2, 1999, Pages 104-106
|
The mother-to-child hiv transmission debate
a a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ZIDOVUDINE;
COST BENEFIT ANALYSIS;
DISEASE TRANSMISSION;
ECONOMICS;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NEWBORN;
NOTE;
PREGNANCY;
PREGNANCY COMPLICATION;
SOUTH AFRICA;
ANTI-HIV AGENTS;
COST-BENEFIT ANALYSIS;
DISEASE TRANSMISSION, VERTICAL;
FEMALE;
HIV INFECTIONS;
HUMANS;
INFANT, NEWBORN;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
SOUTH AFRICA;
ZIDOVUDINE;
|
EID: 0033069615
PISSN: 02569574
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (1)
|